{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T08:38:46Z","timestamp":1791362326439,"version":"4.3.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T00:00:00Z","timestamp":1644278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K15654"],"award-info":[{"award-number":["20K15654"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Kuribayashi foundation","award":["2-2"],"award-info":[{"award-number":["2-2"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Hemangiosarcoma (HSA) is a malignant tumor derived from endothelial cells. Tumor-associated macrophages are one of the major components of tumor microenvironment and crucial for cancer development. The presence and function of macrophages in HSA have not been studied because there is no syngeneic model for HSA. In this study, we evaluated two mouse HSA cell lines and one immortalized mouse endothelial cell\u00a0line for their usefulness as syngeneic models for canine HSA. Our results showed that the ISOS-1 cell line developed tumors with similar morphology to canine HSA. ISOS-1 cells highly expressed KDM2B and had similar KDM2B target expression patterns with canine HSA. Moreover, we determined that in both ISOS-1 and canine HSA tumors, macrophages were present as a major constituent of the tumor microenvironment. These macrophages were positive for CD204, an M2 macrophage marker, and express PD-L1, an immune checkpoint molecule. Canine HSA with macrophages expressing PD-L1 had a smaller number of T-cells in tumor tissues\u00a0than\u00a0tumors with PD-L1 negative macrophages. ISOS-1-conditioned medium could induce M2 polarization and PD-L1 expression in RAW264.7 mouse macrophage cell line and mouse peritoneal macrophages. These results show that ISOS-1 can be used as a syngenic model for canine HSA and suggest that macrophages play an important role in immune evasion in HSA. Using the syngeneic mouse model for canine HSA, we can further study the role of immune cells in the pathology of HSA.<\/jats:p>","DOI":"10.1038\/s41598-022-06203-w","type":"journal-article","created":{"date-parts":[[2022,2,8]],"date-time":"2022-02-08T06:04:34Z","timestamp":1644300274000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hemangiosarcoma cells induce M2 polarization and PD-L1 expression in macrophages"],"prefix":"10.1038","volume":"12","author":[{"given":"Kevin Christian M.","family":"Gulay","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Aoshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Maekawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamami","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Konnai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,2,8]]},"reference":[{"key":"6203_CR1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2460\/javma.1992.200.06.829","volume":"200","author":"WL Spangler","year":"1992","unstructured":"Spangler, W. L. & Culbertson, M. R. Prevalence, type, and importance of splenic diseases in dogs: 1,480 cases (1985\u20131989). J. Am. Vet. Med. Assoc. 200, 829\u2013834 (1992).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"6203_CR2","first-page":"706","volume":"193","author":"C Prymak","year":"1988","unstructured":"Prymak, C., McKee, L. J., Goldschmidt, M. H. & Glickman, L. T. Epidemiologic, clinical, pathologic, and prognostic characteristics of splenic hemangiosarcoma and splenic hematoma in dogs: 217 cases (1985). J. Am. Vet. Med. Assoc. 193, 706\u2013712 (1988).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"6203_CR3","doi-asserted-by":"publisher","first-page":"1851","DOI":"10.2460\/javma.231.12.1851","volume":"231","author":"CM Johannes","year":"2007","unstructured":"Johannes, C. M. et al. Hemangiosarcoma in cats: 53 cases (1992\u20132002). J. Am. Vet. Med. Assoc. 231, 1851\u20131856 (2007).","journal-title":"J. Am. Vet. Med. Assoc."},{"key":"6203_CR4","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1111\/j.1939-1676.2000.tb01508.x","volume":"14","author":"LL Southwood","year":"2000","unstructured":"Southwood, L. L. et al. Disseminated hemangiosarcoma in the horse: 35 cases. J. Vet. Intern. Med. 14, 105\u2013109 (2000).","journal-title":"J. Vet. Intern. Med."},{"key":"6203_CR5","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/toxsci\/kfp131","volume":"111","author":"SM Cohen","year":"2009","unstructured":"Cohen, S. M. et al. Hemangiosarcoma in rodents: Mode-of-action evaluation and human relevance. Toxicol. Sci. 111, 4\u201318 (2009).","journal-title":"Toxicol. Sci."},{"key":"6203_CR6","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1016\/S1470-2045(10)70023-1","volume":"11","author":"RJ Young","year":"2010","unstructured":"Young, R. J., Brown, N. J., Reed, M. W., Hughes, D. & Woll, P. J. Angiosarcoma. Lancet Oncol. 11, 983\u2013991 (2010).","journal-title":"Lancet Oncol."},{"key":"6203_CR7","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1016\/j.jgg.2021.02.005","volume":"48","author":"KCM Gulay","year":"2021","unstructured":"Gulay, K. C. M. et al. KDM2B promotes cell viability by enhancing DNA damage response in canine hemangiosarcoma. J. Genet. Genomics 48, 618\u2013630 (2021).","journal-title":"J. Genet. Genomics"},{"key":"6203_CR8","first-page":"545","volume":"9","author":"ZG Lei","year":"2016","unstructured":"Lei, Z. G., Ren, X. H., Wang, S. S., Liang, X. H. & Tang, Y. L. Immunocompromised and immunocompetent mouse models for head and neck squamous cell carcinoma. Onco Targets Ther. 9, 545 (2016).","journal-title":"Onco Targets Ther."},{"key":"6203_CR9","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/S0923-1811(97)00032-7","volume":"16","author":"M Masuzawa","year":"1998","unstructured":"Masuzawa, M. et al. Establishment of a new murine-phenotypic angiosarcoma cell line (ISOS-1). J. Dermatol. Sci. 16, 91\u201398 (1998).","journal-title":"J. Dermatol. Sci."},{"key":"6203_CR10","first-page":"5526","volume":"50","author":"K Toda","year":"1990","unstructured":"Toda, K. et al. Establishment and characterization of a tumorigenic murine vascular endothelial cell line (F-2). Cancer Res. 50, 5526\u20135530 (1990).","journal-title":"Cancer Res."},{"key":"6203_CR11","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1600-065X.2008.00607.x","volume":"222","author":"P Allavena","year":"2008","unstructured":"Allavena, P., Sica, A., Garlanda, C. & Mantovani, A. The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol. Rev. 222, 155\u2013161 (2008).","journal-title":"Immunol. Rev."},{"key":"6203_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12929-019-0568-z","volume":"26","author":"Y Chen","year":"2019","unstructured":"Chen, Y. et al. Tumor-associated macrophages: An accomplice in solid tumor progression. J. Biomed. Sci. 26, 1\u201313 (2019).","journal-title":"J. Biomed. Sci."},{"key":"6203_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1681\/ASN.2010030269","volume":"22","author":"Y Wang","year":"2011","unstructured":"Wang, Y. & Harris, D. C. H. Macrophages in renal disease. J. Am. Soc. Nephrol. 22, 21\u201327 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"6203_CR14","first-page":"36","volume":"21","author":"M Nagano","year":"2021","unstructured":"Nagano, M. et al. CD204-positive macrophages accumulate in breast cancer tumors with high levels of infiltrating lymphocytes and programmed death ligand-1 expression. Oncol. Lett. 21, 36 (2021).","journal-title":"Oncol. Lett."},{"key":"6203_CR15","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1038\/s41598-017-01661-z","volume":"7","author":"K Kubota","year":"2017","unstructured":"Kubota, K. et al. CD163+CD204+ tumor-associated macrophages contribute to T cell regulation via interleukin-10 and PD-L1 production in oral squamous cell carcinoma. Sci. Rep. 7, 1755 (2017).","journal-title":"Sci. Rep."},{"key":"6203_CR16","doi-asserted-by":"publisher","first-page":"2692","DOI":"10.4049\/jimmunol.164.5.2692","volume":"164","author":"ML Fitzgerald","year":"2000","unstructured":"Fitzgerald, M. L., Moore, K. J., Freeman, M. W. & Reed, G. L. Lipopolysaccharide induces scavenger receptor A expression in mouse macrophages: A divergent response relative to human THP-1 monocyte\/macrophages. J. Immunol. 164, 2692\u20132700 (2000).","journal-title":"J. Immunol."},{"key":"6203_CR17","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1016\/j.atherosclerosis.2017.10.005","volume":"266","author":"R Hashimoto","year":"2017","unstructured":"Hashimoto, R. et al. LPS enhances expression of CD204 through the MAPK\/ERK pathway in murine bone marrow macrophages. Atherosclerosis 266, 167\u2013175 (2017).","journal-title":"Atherosclerosis"},{"key":"6203_CR18","first-page":"372","volume":"6","author":"T Kitajima","year":"1994","unstructured":"Kitajima, T., Iwashiro, M., Kuribayashi, K. & Imamura, S. Immunological characterization of tumor-rejection antigens on ultraviolet-light-induced tumors originating in the CB6F1 mouse. Cancer Immunol. Immunother. 6, 372\u2013378 (1994).","journal-title":"Cancer Immunol. Immunother."},{"key":"6203_CR19","doi-asserted-by":"publisher","DOI":"10.1098\/rsob.200148","volume":"10","author":"L Zhou","year":"2020","unstructured":"Zhou, L., Jilderda, L. J. & Foijer, F. Exploiting aneuploidy-imposed stresses and coping mechanisms to battle cancer. Open Biol. 10, 200148 (2020).","journal-title":"Open Biol."},{"key":"6203_CR20","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157176","volume":"11","author":"N Maekawa","year":"2016","unstructured":"Maekawa, N. et al. Immunohistochemical analysis of PD-L1 expression in canine malignant cancers and PD-1 expression on lymphocytes in canine oral melanoma. PLoS\u00a0One 11, e0157176 (2016).","journal-title":"PLoS\u00a0One"},{"key":"6203_CR21","doi-asserted-by":"publisher","first-page":"8951","DOI":"10.1038\/s41598-017-09444-2","volume":"7","author":"N Maekawa","year":"2017","unstructured":"Maekawa, N. et al. A canine chimeric monoclonal antibody targeting PD-L1 and its clinical efficacy in canine oral malignant melanoma or undifferentiated sarcoma. Sci. Rep. 7, 8951 (2017).","journal-title":"Sci. Rep."},{"key":"6203_CR22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41698-020-00139-y","volume":"5","author":"N Maekawa","year":"2021","unstructured":"Maekawa, N. et al. PD-L1 immunohistochemistry for canine cancers and clinical benefit of anti-PD-L1 antibody in dogs with pulmonary metastatic oral malignant melanoma. npj Precis. Oncol. 5, 1\u20139 (2021).","journal-title":"npj Precis. Oncol."},{"key":"6203_CR23","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1042\/bj20020344","volume":"366","author":"T Kitamura","year":"2002","unstructured":"Kitamura, T. et al. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem. J. 366, 737\u2013744 (2002).","journal-title":"Biochem. J."},{"key":"6203_CR24","first-page":"193","volume-title":"In Vivo Immunology Histophysiology of the Lymphoid System","author":"ASG Curtis","year":"2012","unstructured":"Curtis, A. S. G. & Renshaw, R. M. Lymphocyte-endothelial interactions and histocompatibility restriction. In In Vivo Immunology Histophysiology of the Lymphoid System (ed. Nieuwenhuis, P.) 193\u2013198 (Springer US, 2012)."},{"key":"6203_CR25","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1016\/0092-8674(78)90101-0","volume":"15","author":"WC Raschke","year":"1978","unstructured":"Raschke, W. C., Baird, S., Ralph, P. & Nakoinz, I. Functional macrophage cell lines transformed by Abelson leukemia virus. Cell 15, 261\u2013267 (1978).","journal-title":"Cell"},{"key":"6203_CR26","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1746-6148-8-128","volume":"8","author":"A Murai","year":"2012","unstructured":"Murai, A. et al. Constitutive phosphorylation of the mTORC2\/Akt\/4E-BP1 pathway in newly derived canine hemangiosarcoma cell lines. BMC Vet. Res. 8, 128 (2012).","journal-title":"BMC Vet. Res."},{"key":"6203_CR27","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/0923-2508(93)90057-9","volume":"144","author":"R Harasawa","year":"1993","unstructured":"Harasawa, R. et al. Detection and tentative identification of dominant mycoplasma species in cell cultures by restriction analysis of the 16S\u201323S rRNA intergenic spacer regions. Res. Microbiol. 144, 489\u2013493 (1993).","journal-title":"Res. Microbiol."},{"key":"6203_CR28","doi-asserted-by":"publisher","first-page":"859","DOI":"10.1111\/j.1348-0421.2005.tb03675.x","volume":"49","author":"R Harasawa","year":"2005","unstructured":"Harasawa, R. et al. Rapid detection and differentiation of the major mycoplasma contaminants in cell cultures using real-time PCR with SYBR green I and melting curve analysis. Microbiol. Immunol. 49, 859\u2013863 (2005).","journal-title":"Microbiol. Immunol."},{"key":"6203_CR29","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.1038\/s41598-018-37130-4","volume":"9","author":"J Wang","year":"2019","unstructured":"Wang, J., Niu, N., Xu, S. & Jin, Z. G. A simple protocol for isolating mouse lung endothelial cells. Sci. Rep. 9, 1458 (2019).","journal-title":"Sci. Rep."},{"key":"6203_CR30","volume":"91","author":"KL DeCicco-Skinner","year":"2014","unstructured":"DeCicco-Skinner, K. L. et al. Endothelial cell tube formation assay for the in vitro study of angiogenesis. J. Vis. Exp. 91, e51312 (2014).","journal-title":"J. Vis. Exp."},{"key":"6203_CR31","doi-asserted-by":"publisher","first-page":"671","DOI":"10.1038\/nmeth.2089","volume":"9","author":"CA Schneider","year":"2012","unstructured":"Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH Image to ImageJ: 25 years of image analysis. Nat. Methods 9, 671\u2013675 (2012).","journal-title":"Nat. Methods"},{"key":"6203_CR32","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.3389\/fimmu.2018.01650","volume":"9","author":"A Vidyarthi","year":"2018","unstructured":"Vidyarthi, A. et al. TLR-3 stimulation skews M2 macrophages to M1 through IFN-\u03b1\u03b2 signaling and restricts tumor progression. Front. Immunol. 9, 1650 (2018).","journal-title":"Front. Immunol."},{"key":"6203_CR33","doi-asserted-by":"publisher","first-page":"1993","DOI":"10.7150\/ijbs.27459","volume":"14","author":"Y Chen","year":"2018","unstructured":"Chen, Y. et al. SAK-HV promotes RAW264.7 cells migration mediated by MCP-1 via JNK and NF-\u03baB pathways. Int. J. Biol. Sci. 14, 1993\u20132002 (2018).","journal-title":"Int. J. Biol. Sci."},{"key":"6203_CR34","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: Open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06203-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06203-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T22:56:21Z","timestamp":1726613781000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-06203-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2,8]]},"references-count":34,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["6203"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-06203-w","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.01.454679","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,2,8]]},"assertion":[{"value":"2 August 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 January 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 February 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2124"}}